The Neonatal Screening Profile type 2 test is a laboratory test performed on newborns to screen for a range of genetic and metabolic disorders that may affect their health. This screening is usually carried out during the first days after birth and aims to detect conditions such as inherited metabolic diseases, which can lead to serious health problems if not treated early. The test involves measuring specific levels of substances in a small sample of the baby’s blood, which helps identify potential disorders. Early detection allows doctors to provide appropriate treatment, reducing health risks and improving the chances of healthy growth for the baby. It is important for the results of this test to be interpreted by a specialist to ensure accurate understanding and proper treatment plans.